Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Carcinoma, Ovarian Epithelial × Clarithromycin × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, B-Cell, Marginal Zone 1 Carcinoma, Ovarian Epithelial 1

Interventions

fluzoparib 1 envafolimab 1 apatinib 1 Surgical Procedures, Operative 1 Paclitaxel 1 Neoadjuvant Therapy 1 Losartan 1 Drug Therapy 1 Clarithromycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07341100 2026-01-14

Study to Evaluate the Preliminary Efficacy of SKB264 and the Effect of Clarithromycin on the PK of SKB264 in OC

Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.

Phase 2 Not yet recruiting

Carcinoma, Ovarian Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡